Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saccharomyces cerevisiae and Reduced Inflammation

Research synthesisLow evidenceModerate effect6 studies · 6 beneficial · 0 neutral · 0 harmful

Across 6 studies, all reported beneficial effects on inflammation, with effect sizes ranging from small to large but predominantly moderate. The only human RCT (n=12) showed moderate beneficial effects on microvascular inflammatory responses. Most evidence comes from in vitro and animal studies, and no consistent dose or form was reported.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Additionally, the evidence base is limited by a lack of high-quality human studies; only one small RCT (n=12) has been conducted, with the remainder being in vitro or animal studies. Doses and forms were not consistently reported, limiting applicability.

Generated Jul 11, 2026
7 of 7 papers
Back to top